|
2022
|
Invention
|
Ketone bodies and ketone body esters as blood lipid lowering agents.
The subject disclosure prov... |
|
2021
|
Invention
|
Compositions containing nucleosides and manganese and their uses.
This invention encompasses met... |
|
2020
|
Invention
|
Compound for use in protecting skin. A method of protecting animal tissue particularly skin, from... |
|
2018
|
Invention
|
Ketone bodies and ketone body esters as blood lipid lowering agents. The subject disclosure provi... |
|
2014
|
Invention
|
Process for producing (r)-3-hydroxybutyl (r)-3-hydroxybutyrate. Embodiments of the present invent... |
|
|
Invention
|
Process for producing (r)-3-hydroxybutyl (r)-3-hydroxybutyrate. A process for the production of (... |
|
2013
|
Invention
|
Compound comprising (r)-3-hydroxybutyrate moieties for use in protecting skin. A method of protec... |
|
2011
|
Invention
|
System and method of producing nondiffracting light sheets by a multiplicity of spatially overlap... |
|
|
Invention
|
Method for treating atherosclerosis or restenosis using microtubule stabilizing agent.
The prese... |
|
|
Invention
|
A3ar agonists for the treatment of uveitis. The present disclosure relates to the use of an A3AR ... |
|
2010
|
Invention
|
Method for detecting hematoma, portable detection and discrimination device and related systems a... |
|
|
Invention
|
Inhibitors of kshv vil6 and human il6. The invention features compositions comprising microRNAs t... |
|
|
Invention
|
Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use. Found in variou... |
|
|
Invention
|
Compositions and methods for the prevention and treatment of lupus nephritis using anti-dsdna ger... |
|
|
Invention
|
Francisella tularensis variants: compositions and methods of use. The present invention provides ... |
|
|
Invention
|
Serological screening for hhv-8 infection using antigen mixtures. The invention provides composit... |
|
2009
|
Invention
|
Device and methods for microwave assisted cryo-sample processing. Embodiments are provided that p... |
|
|
Invention
|
Antiviral activity of the protein scytovirin and methods of use. The present invention features m... |
|
|
Invention
|
Hydroxybutyrate ester and medical use thereof. A compound which is 3-hydroxybutyl 3-hydroxybutyra... |
|
|
Invention
|
Hydroxybutyrate ester and medical use thereof.
A compound which is 3-hydroxybutyl 3-hy... |
|
|
Invention
|
Modified sugar substrates and methods of use. The invention relates generally to functionalized s... |
|
2008
|
Invention
|
Treatment of cancer via targeting of il-13 receptor-alpha2.
Disclosed herein are compositions an... |
|
|
Invention
|
Chimeric sle/dengue type 4 antigenic viruses. Embodiments described herein concern attenuated, St... |
|
|
Invention
|
Methods of glycosylation and bioconjugation. The instant invention provides isolated catalytic do... |
|
|
Invention
|
Steroid compounds, compositions, and methods of treatment. The instant invention is directed towa... |
|
|
Invention
|
Slco1b3 genotype. The invention relates methods of identifying and predicting inter-patient diffe... |
|
2007
|
Invention
|
Uses of muramyl dipeptide (mdp) for treating inflammation. The present invention provides a metho... |
|
|
Invention
|
Rnase a peptides, fragments and uses thereof. The present invention features isolated polypeptide... |
|
|
Invention
|
Viral nucleic acid microarray and method of use. The present invention relates generally to metho... |
|
|
Invention
|
Broad spectrum antiviral compositions. The instant invention provides compositions and methods fo... |
|
2006
|
Invention
|
Methods and compositions for inhibiting cell death or enhancing cel proliferation.
Th... |
|
|
Invention
|
Use of chk2 kinase inhibitors for cancer treatment. Described herein are Chk2 -inhibitor compound... |
|
|
Invention
|
Hiv tev compositions and methods of use.
The disclosure encompasses p28TEV polypeptide, polynucl... |
|
2005
|
Invention
|
Carcinoembryonic antigen (cea) peptides.
The present invention relates to novel modified CEA ago... |
|
|
Invention
|
Prostate specific antigen oligoepitope peptide.
The invention is a prostate specific antigen oli... |
